Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma Journal Article


Authors: Apolo, A. B.; Ballman, K. V.; Sonpavde, G.; Berg, S.; Kim, W. Y.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D. M.; Grivas, P.; Chatta, G.; Reichert, Z. R.; Kim, J. W.; Bilen, M. A.; McGregor, B.; Singh, P.; Tripathi, A.; Cole, S.; Simon, N.; Niglio, S.; Ley, L.; Cordes, L.; Srinivas, S.; Huang, J; Odegaard, M.; Watt, C; Petrylak, D; Hoffman‑Censits, J.; Wen, Y.; Hahn, O; Mitchell, C.; Tan, A.; Streicher, H.; Sharon, E.; Moon, H.; Woods, M.; Halabi, S.; Perez Burbano, G.; Morris, M. J.; Rosenberg, J. E.
Article Title: Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma
Journal Title: New England Journal of Medicine
Volume: 392
Issue: 1
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2025-01-02
Start Page: 45
End Page: 55
DOI: 10.1056/NEJMoa2401726
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
PMCID: PMC11698643
PUBMED: 39282902
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record -- Source: CINAHL Plus with Full Text
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    579 Morris
  2. Jonathan Eric Rosenberg
    513 Rosenberg
  3. Min Yuen   Teo
    105 Teo